Literature DB >> 6990257

Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

G G Glenner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6990257     DOI： 10.1056/NEJM198006123022403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  115 in total

Review 1.  Amyloidosis and the respiratory tract.

Authors:  J D Gillmore; P N Hawkins
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  Two prion-inducing regions of Ure2p are nonoverlapping.

Authors:  M L Maddelein; R B Wickner
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

3.  Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.

Authors:  G L Zanusso; G Moretto; B Bonetti; S Monaco; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1992-09

Review 4.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 5.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors:  Sam Gandy; Steven T DeKosky
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

6.  Primary cardiovascular amyloidosis with benign monoclonal gammopathy.

Authors:  L Pajor; G Kelényi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

7.  Novel Antibody for the Treatment of Transthyretin Amyloidosis.

Authors:  Akihiko Hosoi; Yu Su; Masaharu Torikai; Hirofumi Jono; Daisuke Ishikawa; Kenji Soejima; Hirofumi Higuchi; Jianying Guo; Mitsuharu Ueda; Genki Suenaga; Hiroaki Motokawa; Tokunori Ikeda; Satoru Senju; Toshihiro Nakashima; Yukio Ando
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

8.  Cerebral amyloid angiopathy associated with massive intracerebral hemorrhage.

Authors:  D F Sobel; E Baker; B Anderson; H Kretzschmar
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

9.  'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils.

Authors:  D Caspi; M L Baltz; A Feinstein; E A Munn; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

10.  The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis.

Authors:  M L Baltz; D Caspi; B E Glatthaar; U Moser; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.